Homocysteine is a bystander for ST-segment elevation myocardial infarction: a case-control study

Homocysteine is a bystander for ST-segment elevation myocardial infarction: a case-control study

Abstract Background Homocysteine has been long considered a risk factor for atherosclerosis. However, cardiovascular events cannot be reduced through homocysteine lowering by B vitamin supplements. Although several association studies have reported an elevation of serum homocysteine levels in cardio...

Full description

Bibliographic Details
Main Authors: Ching-Yu Julius Chen, Tzu-Ching Yang, Christopher Chang, Shao-Chun Lu, Po-Yuan Chang
Format: Article
Language:English
Published: BMC 2018-02-01
Series:BMC Cardiovascular Disorders
Subjects:
Coronary artery disease
C-reactive protein (CRP)
Homocysteine
ST-segment elevation myocardial infarction (STEMI)
White blood cell (WBC)
Online Access:http://link.springer.com/article/10.1186/s12872-018-0774-8

Internet

http://link.springer.com/article/10.1186/s12872-018-0774-8

Similar Items